A fact I recently learnedI recently finished reading a book on automata, and according to that book, Turing machines, lambda calculus, and recursive functions all have the same computational ...

If AI evolves, won't drug discovery become more successful?I have high expectations for the future. Beyond obesity and lifestyle-related diseases, this could provide new options for people who are not ...

The AI industry is colliding with two hard limits at once. Positron AI co-founder Thomas Sohmers argues the binding constraint on inference is ...

Kim Ki-beom, CEO of 10x Builders and a former Google engineer, assessed that AI already possesses coding capabilities ...

AI spending dwarfs past tech booms, but economists say the productivity gains needed to justify trillions in outlays remain ...

Researchers have developed IGA, an unsupervised graph alignment framework that uses isomorphism-aware neural networks to ...

A team of cybersecurity researchers has unveiled an artificial intelligence system that can take a stripped-down binary ...

Headline, the first institutional backer of Mistral and Black Forest Labs, closes a $400M fund targeting Seed and Series A AI ...

Goldman's broader outlook remains constructive. The firm forecasts S&P 500 EPS of $375 for 2026, up 36% from 2025, followed ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Anthropic's IPO prospectus just leaked, and the numbers paint a complicated picture: a $42B loss, nearly $4.6B in revenue, and a rumored $2 trillion valuation that would rank it among the most ...

One of many current controversies over artificial intelligence centers on “alignment”: A euphemism for “trying to build AI that won’t intentionally kill us all.” That’s important, but it overshadows a ...